| Previous close | 12.42 |
| Open | 23.55 |
| Bid | 8.10 |
| Ask | 12.50 |
| Strike | 175.00 |
| Expiry date | 2024-05-17 |
| Day's range | 12.42 - 23.55 |
| Contract range | N/A |
| Volume | |
| Open interest | 36 |
Business WireBeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024
SAN MATEO, Calif., May 14, 2024--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data from its hematology portfolio and pipeline at the European Hematology Association 2024 Hybrid Congress (EHA2024) in Madrid, Spain, June 13-16, 2024. BeiGene has 28 abstracts accepted at EHA2024, with four scheduled for oral presentations.
Simply Wall St.The BeiGene, Ltd. (NASDAQ:BGNE) First-Quarter Results Are Out And Analysts Have Published New Forecasts
A week ago, BeiGene, Ltd. ( NASDAQ:BGNE ) came out with a strong set of quarterly numbers that could potentially lead...
Simply Wall St.BeiGene First Quarter 2024 Earnings: Beats Expectations
BeiGene ( NASDAQ:BGNE ) First Quarter 2024 Results Key Financial Results Revenue: US$751.7m (up 68% from 1Q 2023). Net...
© 2024 Yahoo. All rights reserved.